Eli Lilly and Company
Compounds useful for inhibiting ROR-gamma-t
Last updated:
Abstract:
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof. Formula (I).
Status:
Grant
Type:
Utility
Filling date:
27 Feb 2018
Issue date:
31 Mar 2020